Home > Boards > Stock Clubs > Market Trends and Strategies > $heff's $tation of $tocks & $olid DD

New Economy Portfolio..bought a stock that is trading

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
$heff Member Profile
Followed By 3,235
Posts 32,624
Boards Moderated 1
Alias Born 07/08/06
160x600 placeholder
Truist Financial Raises Quarterly Cash Dividend
Truist Financial Corp. on Tuesday said its board raised the company's regular quarterly cash dividend by 7%.
Mondelez: Currency Translations to Boost Full-Year Revenue Growth -- Currency Comment
Visa Profit, Net Revenue Climbs with Payments Volume Increasing
Mondelez Raises Fiscal Year Organic Net Revenue Growth Outlook
U.S. Crude-Oil Stockpiles Likely to Fall in DOE Data, Analysts Say -- Update
Top Company News of the Day
Stryker Swings to 2Q Profit as Pandemic Moderated
Starbucks Says Foreign Exchange Rates Boosted 3Q Revenue -- Currency Comment
AMD Raises Revenue Guidance Following Better-than-Expected 2Q Performance
Mondelez 2Q Profit Nearly Doubles As Sales Rise on Consumer Demand
ObsEva Shares Climb 10% on Licensing Deal With Organon
Wheat Slides as Traders Take Tentative Stance -- Daily Grain Highlights
Front Month Nymex RBOB Gasoline Rose 0.25% to Settle at $2.3141 -- Data Talk
Front Month Nymex Natural Gas Fell 3.19% to Settle at $3.9710 -- Data Talk
Boston Scientific Third Best Performer in the S&P 500 So Far Today -- Data Talk
Shell New Energies to Buy Inspire Energy Capital
Yum China Down Over 6%, on Pace for Largest Percent Decrease Since May 2020 -- Data Talk
Rio Tinto Commits $2.4 Billion to Serbian Lithium Project
Europcar Confirms Advanced Takeover Talks With Volkswagen Consortium
Rio Tinto Commits $2.4 Billion to Lithium Project in Serbia -- Commodity Comment
Casino, Credit Mutuel to Sell Payment Provider to BNP Paribas for EUR258 Million
$heff   Monday, 11/30/15 11:45:44 AM
Re: $heff post# 91644
Post # of 97234 
New Economy Portfolio..bought a stock that is trading like it wants to move much higher soon. For folks that missed my $SYN alert at $2.20 last week (it’s $3.00 now) this stock is near the same price that stock was at $2.20 range before heading higher. Lots of catalysts here moving forward. A licensing deal by YE, Updated Ph 1 data at HepDart 2015 2nd week of December, also expecting word from FDA on IND filing for HBV, Ph 2 studies to commence in 2016. This company which has a pro drug similar to Gilead’s Tenofovir has been discussed as being better tolerated that the gold standard. Company has a market cap under $60m and bought CMX-157 from Chimerix (2B marketcap). 52wk low is $1.05 & 52wk high is $6.28.

Alert..bought $CTRV at $2.13 in the New Economy Portfolio with a 15% (Full) position. This stock has excellent prospects moving forward.

ContraVirPharma: #HepatitisB is the next frontier! $CTRV CEO in @Bloomberg ‘Hepatitis Quest Moves From C to B Under Ex-Gilead Leaders’ http://t.co/sgwuyOntBn

@ContraVirPharma: We plan to file an IND for CMX157 to treat #HBV before year-end 2015, Ph 2 Study to commence in 2016 http://t.co/bDjUpIv3Mr $CTRV

$CTRV Public Offering Results in $15 Million of Gross Proceeds - @DavidBautz >> https://t.co/qSPOEYPx9X (Did the offering at $3/share. Price now at $2.15)

The Life Sciences Report-$CTRV ..http://bit.ly/1RdXAJr

$CTRV..October Presentation Slides.. http://bit.ly/1QPHR3Z

$CTRV..Bio-Investor Forum Webcast.. http://bit.ly/1Nlr1aA

Going to do an Audio DD post later today on this stock.

Disclaimer: http://bit.ly/OlN9DB

Bloomberg Business

Sheff's Station...All Aboard...Sign Up Here!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences